3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
3
Cytokine Release Syndrome
2
Schwannomatosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pain
1
Neurilemmoma
1
Neoplasms, Plasma Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Large Granular Lymphocytic
1
Immunoglobulin Light-chain Amyloidosis
1
Chronic Pain
1
Burkitt Lymphoma
1
Advanced Malignant Solid Neoplasm
1
Interventions
Lenalidomide
7
Dexamethasone
5
daratumumab
4
Calcium Dobesilate
4
dexamethasone acetate
3
dexamethasone 21-phosphate
3
auricularum
3
Curcumin
3
isatuximab
2
iberdomide
2
Leflunomide
2
pomalidomide
1
poly ICLC
1
piperine
1
pembrolizumab
1
ixazomib
1
fludarabine phosphate
1
fludarabine
1
citarinostat
1
Watchful Waiting
1
Urination
1
Stem Cell Transplantation
1
Resistance Training
1
Propranolol
1
Probiotics
1
Peripheral Blood Stem Cell Transplantation
1
PVX-410 vaccine
1
Observation
1
Metformin
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Smoldering Multiple Myeloma
×
siltuximab
×
1 year
×
Clear all
No trials found.